Search

Your search keyword '"Walpole, E."' showing total 152 results

Search Constraints

Start Over You searched for: Author "Walpole, E." Remove constraint Author: "Walpole, E." Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
152 results on '"Walpole, E."'

Search Results

3. Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

25. 610O - An AGITG trial –A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel +/-radioTherapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma

27. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

29. Cisplatin-based therapy: a neurological and neuropsychological review.

31. Evaluation of the Mastalex latex agglutination test for methicillin resistance in Staphylococcus aureus grown on different screening media.

35. Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

36. Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma

37. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study.

38. Relapse Patterns after Chemo-radiation for Carcinoma of the Oesophagus

39. Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?

40. Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy.

41. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer.

42. High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.

43. End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysis.

44. Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study.

45. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.

46. Research governance authorisation: the next frontier.

47. Bortezomib use and outcomes for the treatment of multiple myeloma.

48. Antibody/Ligand-Target Receptor Internalization Assay Protocol Using Fresh Human or Murine Tumor Ex Vivo Samples.

49. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?

50. Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes.

Catalog

Books, media, physical & digital resources